{"filings":[{"id":209919,"accession_number":"0001104659-24-087775","cik":1715819,"company_name":"Electromedical Technologies, Inc","ticker":"EMED","form_type":"8-K/A","filed_at":"2024-08-09T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Electromedical Technologies cancels prior share increase, approves 5B authorized shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board and majority shareholders approved on Aug 6, 2024 to increase authorized shares to 5,001,000,001.","Canceled prior July 18, 2024 amendment that set authorized shares at approximately 3 billion.","New authorization: 5B common, 1M Series A preferred, 1 Series B preferred, all $0.00001 par value.","Certificate of Amendment being filed with Delaware Secretary of State; effective upon filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":373228.99999999994,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209920,"accession_number":"0001104659-24-082325","cik":1715819,"company_name":"Electromedical Technologies, Inc","ticker":"EMED","form_type":"8-K","filed_at":"2024-07-24T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"ElectroMedical Tech boosts authorized shares to 3B common + 1M preferred","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board and majority shareholders approved charter amendment raising authorized shares to 3,001,000,001.","Common shares authorized: 3,000,000,000 at $0.00001 par value.","Series A Preferred: 1,000,000 shares; Series B Preferred: 1 share, both $0.00001 par value.","Amendment filed with Delaware Secretary of State, effective upon filing completion.","No stated purpose for the share increase; potential future financing or strategic use."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":373228.99999999994,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228124,"accession_number":"0001104659-24-063695","cik":1715819,"company_name":"Electromedical Technologies, Inc","ticker":"EMED","form_type":"8-K","filed_at":"2024-05-21T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Electromedical Technologies auditor declines reelection; going concern noted; Hudgens appointed","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["dbbmckennon declined to stand for reelection as independent auditor on May 17, 2024; no disagreements or reportable events.","Hudgens, CPA, PLLC engaged as new principal accountant to audit financial statements.","Prior auditor reports included a going concern explanatory paragraph due to recurring losses and working capital deficit.","No consultations occurred between the company and Hudgens on accounting principles or audit opinions before engagement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":373228.99999999994,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228123,"accession_number":"0001104659-24-042335","cik":1715819,"company_name":"Electromedical Technologies, Inc","ticker":"EMED","form_type":"8-K","filed_at":"2024-04-02T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Electromedical settles defaults with Mast Hill Fund; cancels warrants, extends maturity","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Settled defaults on three security purchase agreements dated Oct 2021, Feb 2022, and Sep 2022.","All outstanding warrants cancelled; interest and default interest waived until new maturity Sep 25, 2025.","Interest accrues at 12% per annum; repayment includes 15% of any capital raised while notes outstanding.","Company also agrees to pay Mast Hill a pro-rata portion of proceeds from current and future product sales."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":373228.99999999994,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":281568,"accession_number":"0001104659-23-077975","cik":1715819,"company_name":"Electromedical Technologies, Inc","ticker":"EMED","form_type":"8-K","filed_at":"2023-07-05T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Independent director Robert L. Hymers III resigns from board of Electromedical Technologies","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Robert L. Hymers III resigned as independent director effective July 1, 2023.","No disagreement with the company on any disclosable matter per Item 5.02(a).","Hymers provided a letter of resignation filed as an exhibit, agreeing with company's disclosures."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":373228.99999999994,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":300419,"accession_number":"0001104659-23-047605","cik":1715819,"company_name":"Electromedical Technologies, Inc","ticker":"EMED","form_type":"8-K","filed_at":"2023-04-20T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"ElectroMedical reports use-of-proceeds from property sale; $650K on Wellness Pro Plus","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Net proceeds from March real estate sale: $1,358,710.56 (purchase price $2,000,000).","Spent $290k on R&D, $150k on testing/tooling, $210k on inventory for the Wellness Pro Plus Infinity product.","Total $650k deployed on product development; remaining proceeds not disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":373228.99999999994,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":320439,"accession_number":"0001104659-23-035011","cik":1715819,"company_name":"Electromedical Technologies, Inc","ticker":"EMED","form_type":"8-K","filed_at":"2023-03-21T23:59:59+00:00","items":["1.01","2.01","9.01"],"status":"ready","headline":"Electromedical sells headquarters property for $2M, leases it back for $9K/month","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold real property at 16561 N. 92nd St., Scottsdale, AZ for $2,000,000. Net proceeds: $1,358,710.56.","Sale extinguishes all outstanding mortgage debt on the property, including principal and interest.","Entered one-year commercial lease for the same office (Unit D101) at $9,000 monthly rent.","No relationship exists between the company and buyer Care National Healthcare Services, Inc."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":373228.99999999994,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":320438,"accession_number":"0001104659-23-009306","cik":1715819,"company_name":"Electromedical Technologies, Inc","ticker":"EMED","form_type":"8-K","filed_at":"2023-02-01T23:59:59+00:00","items":["3.03","5.01","5.02","5.03"],"status":"ready","headline":"CEO Matthew Wolfson granted voting control via Series B preferred; authorized shares increased to 2B+","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Employment agreement gives Wolfson one Series B preferred share with voting control equal to all common shares plus 100k votes on fully diluted basis.","Wolfson retains $265k/yr CEO salary plus $100k/yr CFO salary; incentives include up to 25M common shares for annual growth and cash bonuses for quarterly growth.","Robert L. Hymers III appointed as independent director and compensation committee member for 6-month term; receives $5k monthly in common shares.","Charter amendment increases authorized capital to 2,000,000,001 shares (199M common, 1M Series A preferred, 1 Series B preferred); filed with Delaware."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":373228.99999999994,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":338585,"accession_number":"0001104659-22-129860","cik":1715819,"company_name":"Electromedical Technologies, Inc","ticker":"EMED","form_type":"8-K","filed_at":"2022-12-23T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Electromedical Technologies appoints Petar Gajic, Robert L. Hymers III to board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointed Petar Gajic and Robert L. Hymers III to board of directors on Dec 20, 2022.","Appointed by written consent of shareholder owning 60.04% of eligible votes.","No arrangement or understanding for selection; compensation has not yet been set.","Will amend 8-K within four days if committee membership or compensation determined."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":373228.99999999994,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":338584,"accession_number":"0001104659-22-128618","cik":1715819,"company_name":"Electromedical Technologies, Inc","ticker":"EMED","form_type":"8-K","filed_at":"2022-12-20T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Lee Benson resigns over compensation policy disagreement","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Lee Benson resigned as independent director on Dec 12, 2022, citing a disagreement with compensation policy.","Company provided Benson with a copy of the disclosures and offered opportunity to respond with a letter.","Any letter from Benson will be filed as an exhibit by amendment within two business days of receipt.","CEO Matthew Wolfson signed the filing; no replacement director named."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":373228.99999999994,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":355947,"accession_number":"0001104659-22-102659","cik":1715819,"company_name":"Electromedical Technologies, Inc","ticker":"EMED","form_type":"8-K","filed_at":"2022-09-23T23:59:59+00:00","items":["3.02","5.01","5.03"],"status":"ready","headline":"CEO receives super-voting preferred shares, now controls 75.48% of voting power","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 500,000 Series A Preferred shares to CEO Matthew Wolfson as retention consideration; each share carries 100 votes.","Wolfson now holds 1M Series A Preferred and 15.4M common shares, representing 75.48% of total voting power.","Board increased authorized shares to 999M common, 1M Series A Preferred, and 1 Series B Preferred, approved by written consent.","Wolfson committed to remain as PEO and PFO while employment agreement amendments are finalized."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":373228.99999999994,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":355946,"accession_number":"0001104659-22-080443","cik":1715819,"company_name":"Electromedical Technologies, Inc","ticker":"EMED","form_type":"8-K","filed_at":"2022-07-18T23:59:59+00:00","items":["1.01","3.02"],"status":"ready","headline":"ElectroMedical settles $668K debt with 26.7M shares to JR-HD Enterprises III","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Settled five promissory notes totaling $617,353 principal + $51,017 accrued interest via restricted common stock.","Issued 26,734,800 shares of restricted common stock on July 6, 2022 as consideration.","Shares issued to JR-HD Enterprises III, LLC; exemption from registration claimed under Rule 4(a)(2).","Board approved settlement on July 4, 2022; agreement entered on June 21, 2022.","No material relationship between company and noteholder beyond the notes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":373228.99999999994,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":374259,"accession_number":"0001104659-22-070496","cik":1715819,"company_name":"Electromedical Technologies, Inc","ticker":"EMED","form_type":"8-K","filed_at":"2022-06-13T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Electromedical Technologies appoints Lee Benson as independent director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Lee Benson, age 61, appointed independent director effective June 7, 2022.","Compensation: $5,000 monthly salary payable in common shares.","Benson founded Able Aerospace, grew it from 3 to 500+ employees, sold to Textron Aviation.","No family relationships or related transactions with the company disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":373228.99999999994,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":392830,"accession_number":"0001104659-22-035723","cik":1715819,"company_name":"Electromedical Technologies, Inc","ticker":"EMED","form_type":"8-K","filed_at":"2022-03-21T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Electromedical increases authorized shares to 501M; amends quorum requirement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board amended By-Laws to set quorum at one-third of shares entitled to vote, per Delaware law.","Board and stockholders approved increase in authorized capital stock to 501M shares (500M common, 1M Series A, 1 Series B).","Amendment to Certificate of Incorporation filed with Delaware Secretary of State on March 14, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":373228.99999999994,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":411237,"accession_number":"0001104659-21-128200","cik":1715819,"company_name":"Electromedical Technologies, Inc","ticker":"EMED","form_type":"8-K","filed_at":"2021-10-21T23:59:59+00:00","items":["1.01","3.03","5.03","8.01","9.01"],"status":"ready","headline":"ElectroMedical Tech raises $750K via convertible notes; charter amendment gives super-voting to Series B Preferred","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Mast Hill Fund lends $500K (10% interest, OID $50K) and Talos Victory Fund $250K (10% interest, OID $25K); each convertible at $0.06/share.","5-year warrants issued: 4,166,666 shares at $0.12 per share to Mast Hill; 2,083,333 shares at $0.12 per share to Talos.","Board increased authorized common stock to 250M shares; created Series B Preferred Share with super-voting rights (issued shares + 100K votes).","Warrant cancellations: Vista Capital gets 1M restricted shares; Jefferson Street cancels remainder after $750K financing condition met.","Yorkville debentures fully converted and satisfied; warrant exercise price adjusted to $0.025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":373228.99999999994,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}